PAPER Bouter Y, Noguerola JS, Tucholla P, Crespi GA, Parker MW, Wiltfang J, Miles LA, Bayer TA
SEARCH RESULTS
330978 RESULTS
PAPER Yuan M, Lian S, Li X, Long X, Fang Y, Alzheimer's Disease Neuroimaging Initiative (ADNI)
Blood biomarkers in dynamic prediction of conversion to Alzheimer's disease: An application of joint modeling.
Int J Geriatr Psychiatry. 2024 Mar;39(3):e6079. PubMed: 38526446PAPER Lindner K, Gavin AC
Isoform- and cell-state-specific APOE homeostasis and function.
Neural Regen Res. 2024 Nov 1;19(11):2456-2466. Epub 2024 Jan 31 PubMed: 38526282PAPER
Corrigendum: Genistein suppresses mitochondrial apoptotic pathway in rat hippocampal neurons with Alzheimer's disease.
Neural Regen Res. 2024 Nov 1;19(11):2429. Epub 2024 Mar 8 PubMed: 38526279PAPER Hu B, Zhang J, Huang J, Luo B, Zeng X, Jia J
NLRP3/1-mediated pyroptosis: beneficial clues for the development of novel therapies for Alzheimer's disease.
Neural Regen Res. 2024 Nov 1;19(11):2400-2410. Epub 2023 Dec 21 PubMed: 38526276PAPER Chen G, Johansson J
Potential of molecular chaperones for treating Alzheimer's disease.
Neural Regen Res. 2024 Nov 1;19(11):2343-2344. Epub 2024 Mar 8 PubMed: 38526266PAPER Kaur B, Kaur R, Vivesh, Rani S, Bhatti R, Singh P
Small Peptides Targeting BACE-1, AChE, and A-β Reversing Scopolamine-Induced Memory Impairment: A Multitarget Approach against Alzheimer's Disease.
ACS Omega. 2024 Mar 19;9(11):12896-12913. Epub 2024 Mar 4 PubMed: 38524457PAPER Mahdy S, Abuelmakarem HS
Alzheimer's disease progression detection based on optical fluence rate measurements using alternative laser wavelengths.
Int J Numer Method Biomed Eng. 2024 Mar 25;:e3816. PubMed: 38523567PAPER Blurton-Jones M, Spencer B, Michael S, Castello NA, Agazaryan AA, Davis JL, Müller FJ, Loring JF, Masliah E, LaFerla FM
Correction: Neural stem cells genetically-modified to express neprilysin reduce pathology in Alzheimer transgenic models.
Stem Cell Res Ther. 2024 Mar 25;15(1):88. PubMed: 38523285PAPER Vajedi FS, Rasoolzadeh R, Angnes L, Santos EC, Silva LP
Ultrasensitive Aptasensing Platform for the Detection of β-Amyloid-42 Peptide Based on MOF Containing Bimetallic Porphyrin Graphene Oxide and Gold Nanoparticles.
ACS Appl Bio Mater. 2024 Apr 15;7(4):2218-2239. Epub 2024 Mar 25 PubMed: 38527228PAPER Cheong I, Du Y, Smith G, Hua J, Li X, Pantelyat A
Cerebral tau deposition in co-morbid progressive supranuclear palsy and amyotrophic lateral sclerosis: an [18F]-flortaucipir and 7T MRI study.
Neurodegener Dis. 2024 Mar 25; PubMed: 38527450PAPER Robinson CG, Goodrich AW, Weigand SD, Pham NT, Carlos AF, Buciuc M, Murray ME, Nguyen AT, Reichard RR, Knopman DS, Petersen RC, Dickson DW, Utianski RL, Whitwell JL, Josephs KA, Machulda MM
Determinants of confrontation naming deficits on the Boston Naming Test associated with transactive response DNA-binding protein 43 pathology.
J Int Neuropsychol Soc. 2024 Mar 25;:1-9. PubMed: 38525671PAPER Fabjan M, Jurečič A, Jerala M, Oblak JP, Frol S
Recurrent Intracerebral Haematomas Due to Amyloid Angyopathy after Lyodura Transplantation in Childhood.
Neurol Int. 2024 Mar 4;16(2):327-333. PubMed: 38525703PAPER Dallaire-Théroux C, Smith C, Duchesne S
Clinical Predictors of Postmortem Amyloid and Nonamyloid Cerebral Small Vessel Disease in Middle-Aged to Older Adults.
Neurol Clin Pract. 2024 Jun;14(3):e200271. Epub 2024 Mar 21 PubMed: 38525067PAPER Hall MG, Wollman SC, Haines ME, Katschke JL, Boyle MA, Richardson HK, Hammers DB
Clinical validation of an aggregate learning ratio from the neuropsychological assessment battery.
Appl Neuropsychol Adult. 2024 Mar 25;:1-10. PubMed: 38527375Current Filters
- Date Range : All x